Follow
Dániel András Drexler
Dániel András Drexler
Obuda University, Physiological Controls Research Center
Verified email at uni-obuda.hu - Homepage
Title
Cited by
Cited by
Year
Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy
J Sápi, L Kovács, DA Drexler, P Kocsis, D Gajári, Z Sápi
PloS one 10 (11), e0142190, 2015
1662015
Modeling of tumor growth incorporating the effects of necrosis and the effect of bevacizumab
DA Drexler, J Sápi, L Kovács
Complexity 2017 (1), 5985031, 2017
622017
Model-based angiogenic inhibition of tumor growth using modern robust control method
L Kovács, A Szeles, J Sápi, DA Drexler, I Rudas, I Harmati, Z Sápi
Computer Methods and Programs in Biomedicine 114 (3), e98-e110, 2014
612014
Model-based analysis and synthesis of tumor growth under angiogenic inhibition: a case study
DA Drexler, L Kovács, J Sápi, I Harmati, Z Benyó
IFAC Proceedings Volumes 44 (1), 3753-3758, 2011
602011
Assessment and standardization of autonomous vehicles
Á Takács, DA Drexler, P Galambos, IJ Rudas, T Haidegger
2018 IEEE 22nd International Conference on Intelligent Engineering Systems …, 2018
562018
Tumor dynamics modeling based on formal reaction kinetics
DA Drexler, T Ferenci, A Lovrics, L Kovács
Acta Polytechnica Hungarica 16 (10), 31-44, 2019
532019
Experimental data-driven tumor modeling for chemotherapy
DA Drexler, T Ferenci, A Füredi, G Szakács, L Kovács
IFAC-PapersOnLine 53 (2), 16245-16250, 2020
462020
Potential benefits of discrete-time controllerbased treatments over protocol-based cancer therapies
J Sápi, DA Drexler, L Kovács
Acta Polytechnica Hungarica 14 (1), 11-23, 2017
382017
Handover Process of Autonomous Vehicles-technology and application challenges
DA Drexler, A Takács, TD Nagy, T Haidegger
Acta Polytechnica Hungarica 16 (9), 235-255, 2019
372019
A minimal model of tumor growth with angiogenic inhibition using bevacizumab
DA Drexler, J Sápi, L Kovács
2017 IEEE 15th International Symposium on Applied Machine Intelligence and …, 2017
372017
Qualitative analysis of tumor growth model under antiangiogenic therapy–choosing the effective operating point and design parameters for controller design
J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács
Optimal Control Applications and Methods 37 (5), 848-866, 2016
292016
Flat control of tumor growth with angiogenic inhibition
DA Drexler, J Sápi, A Szeles, I Harmati, A Kovács, L Kovács
2012 7th IEEE International Symposium on Applied Computational Intelligence …, 2012
272012
Linear state-feedback control synthesis of tumor growth control in antiangiogenic therapy
J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács
2012 IEEE 10th International Symposium on Applied Machine Intelligence and …, 2012
272012
Positive nonlinear control of tumor growth using angiogenic inhibition
DA Drexler, J Sápi, L Kovács
IFAC-PapersOnLine 50 (1), 15068-15073, 2017
252017
Global controllability of chemical reactions
DA Drexler, J Tóth
Journal of Mathematical Chemistry 54, 1327-1350, 2016
252016
Solution of the closed-loop inverse kinematics algorithm using the Crank-Nicolson method
DA Drexler
2016 IEEE 14th International Symposium on Applied Machine Intelligence and …, 2016
232016
State and parameter estimation of a mathematical carcinoma model under chemotherapeutic treatment
M Siket, G Eigner, DA Drexler, I Rudas, L Kovács
Applied Sciences 10 (24), 9046, 2020
212020
Modeling of tumor growth incorporating the effect of pegylated liposomal doxorubicin
DA Drexler, T Ferenci, A Lovrics, L Kovács
2019 IEEE 23rd International Conference on Intelligent Engineering Systems …, 2019
212019
Experimental Closed‐Loop Control of Breast Cancer in Mice
L Kovács, B Czakó, M Siket, T Ferenci, A Füredi, B Gombos, G Szakács, ...
Complexity 2022 (1), 9348166, 2022
192022
H∞ control of nonlinear systems with positive input with application to antiangiogenic therapy
DA Drexler, J Sápi, L Kovács
IFAC-PapersOnLine 51 (25), 146-151, 2018
192018
The system can't perform the operation now. Try again later.
Articles 1–20